-
Latest News
Archives
Tag Archives: rituximab
Research: Endothelial dysfunction in ME/CFS
Endothelial dysfunction and vascular homestasis in ME/CFS A sub-study of the RituxME trial by Norwegian researchers found a problem in the blood vessels on the heart in a group of people with ME/CFS. Treatment with Rituximab caused a slight … Continue reading
Posted in News
Tagged Christina Særsten Stavland, Dr Olav Mella, Dr Oystein Fluge, Elisabeth Leirgul, endothelial dysfunction, Ingrid Gurvin Rekeland, Kari Sorland, Miriam Kristine Sandvik, rituximab, RituxME, vascular dysfunction
Comments Off on Research: Endothelial dysfunction in ME/CFS
Left out – a Norwegian documentary about ME & research
Left out – a documentary about ME The documentary Left Out (De Bortgjemte) was shown on national TV in Norway in 2018 and now has its international release on YouTube with English subtitles, 29 January 2020. Director Paul Schaathun followed … Continue reading
Posted in News
Tagged documentary, Dr Oystein Fluge, Left out, Pal S Shaathun, rituximab, RituxME
Comments Off on Left out – a Norwegian documentary about ME & research
Endocrine immune regulation in… women with CFS
Leveraging prior knowledge of endocrine immune regulation in the therapeutically relevant phenotyping of women with Chronic Fatigue Syndrome, by Matthew C Morris, Katherine Cooney, Hooman Sedghamiz, Maria Abreu, Fanny Collado, Elizabeth G Balbin, Travis JA Craddock, Nancy G Klimas, Gordon … Continue reading
Posted in News
Tagged Dr Nancy Klimas, Elizabeth G Balbin, endocrine regulation, Fanny Collado, Gordon Broderick, Hooman Sedghamiz, immune regulation, Katherine Cooney, Maria Abreu, Mary Ann Fletcher, Matthew C Morris, numerical modeling, Rintatolimod, rituximab, Travis JA Craddock
Comments Off on Endocrine immune regulation in… women with CFS
B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results
B-lymphocyte depletion in patients With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: a randomized, double-blind, placebo-controlled trial by Oystein Fluge, Ingrid G. Rekeland, Katarina Lien, Hanne Thurmer, Petter C. Borchgrevink, Christoph Schafer, Kari Sorland, Jorg Assmus, Irini Ktoridou-Valen, Ingrid Herder, Merethe E. … Continue reading
Posted in News
Tagged B-lymphocyte depletion, Dr Oystein Fluge, Dr Peter Rowe, Prof Olav Mella, rituxan, rituximab
Comments Off on B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results
Rituximab impedes natural killer cell function in CFS/ME patients
Research abstract: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation by Natalie Eaton, Hélène Cabanas, Cassandra Balinas, Anne Klein, Donald Staines and Sonya Marshall-Gradisnik in BMC Pharmacology and Toxicology 2018 19:12 [Published: … Continue reading
Posted in News
Tagged Anne Klein, blood immune cells, Cassandra Balinas, Hélène Cabanas, Louise Durack, Natalie Eaton, Natural Killer cells, NK cells, Prof Donald Staines, rituximab, Sonya Marshall-Gradisnik
Comments Off on Rituximab impedes natural killer cell function in CFS/ME patients
UK trial of rituximab for ME is no longer practical or even possible to perform
Invest in ME blog post, 11 Feb 2018: Statement following preliminary Phase III Rituximab clinical trial results from Norway Following the preliminary results which Professor Olav Mella recently publicly released from the Phase III multi-centre double-blinded placebo-controlled Rituximab Clinical Trial (see statement 21st November 2017) … Continue reading
Posted in News
Tagged Invest in ME, rituximab
Comments Off on UK trial of rituximab for ME is no longer practical or even possible to perform
Norwegian rituximab trial reports negative results
The Norwegian Rituximab trial reports negative results ahead of the publication of the full results. Attempts are now under way to determine the best way forward in understanding what has been learned and how to find out which patients may still benefit from … Continue reading
Posted in News
Tagged B-cell, Cort Johnson, Cyclophosphamide, Dr Oystein Fluge, Prof Olav Mella, rituximab, Simmaron Research
Comments Off on Norwegian rituximab trial reports negative results
Norwegian Rituximab studies update
Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading
Posted in News
Tagged antibodies, Dr Oystein Fluge, Norway, Prof Olav Mella, rituximab, RituxME
Comments Off on Norwegian Rituximab studies update
The evolution of a ME/CFS researcher? CBT proponent calls for more Herpesvirus research
Simmaron Research blog post, by Cort Johnson, 19 June 2017: The Evolution of a Chronic Fatigue Syndrome (ME/CFS) Researcher? CBT Proponent Calls for More Herpesvirus Research At times Dr. Wyller of Oslo University has seemed more like a Norwegian version … Continue reading
Posted in News
Tagged CBT, cognitive behavioural therapy, Cort Johnson, Herpesvirus, rituximab, V B Wyller
Comments Off on The evolution of a ME/CFS researcher? CBT proponent calls for more Herpesvirus research
UK Rituximab trial collaboration between Norway & UK featured on BBC
BBC Look East video clip, 26 January 2017: Research in Norwich could offer ME/CFS breakthrough Researchers in Norwich are teaming up with researchers from Norway to collaborate on ME/CFS research. The researchers say they believe that ME is reversible, and … Continue reading
Posted in News
Tagged BBC Look East, Dr Oystein Fluge, Invest in ME, Norway, Norwich, Prof Simon Carding, rituximab, video
Comments Off on UK Rituximab trial collaboration between Norway & UK featured on BBC
